ODDO, Salvatore
 Distribuzione geografica
Continente #
EU - Europa 2.244
NA - Nord America 1.721
AS - Asia 1.433
SA - Sud America 523
AF - Africa 41
Continente sconosciuto - Info sul continente non disponibili 10
OC - Oceania 7
Totale 5.979
Nazione #
US - Stati Uniti d'America 1.671
RU - Federazione Russa 1.023
SG - Singapore 756
IE - Irlanda 496
BR - Brasile 461
SE - Svezia 295
HK - Hong Kong 287
CN - Cina 173
IT - Italia 152
DE - Germania 73
IN - India 63
VN - Vietnam 45
FR - Francia 32
NL - Olanda 32
GB - Regno Unito 30
CA - Canada 27
AR - Argentina 25
FI - Finlandia 25
AT - Austria 21
ZA - Sudafrica 20
PL - Polonia 17
BD - Bangladesh 15
JP - Giappone 15
MX - Messico 11
UA - Ucraina 11
EC - Ecuador 9
ES - Italia 9
EU - Europa 9
TR - Turchia 9
AU - Australia 7
CZ - Repubblica Ceca 7
PY - Paraguay 7
VE - Venezuela 7
AE - Emirati Arabi Uniti 6
EG - Egitto 6
ID - Indonesia 6
IQ - Iraq 6
LT - Lituania 6
MY - Malesia 6
CO - Colombia 5
TN - Tunisia 5
UZ - Uzbekistan 5
CL - Cile 4
JO - Giordania 4
KE - Kenya 4
MA - Marocco 4
PK - Pakistan 4
TH - Thailandia 4
TW - Taiwan 4
IL - Israele 3
KZ - Kazakistan 3
LK - Sri Lanka 3
PE - Perù 3
SA - Arabia Saudita 3
AZ - Azerbaigian 2
BE - Belgio 2
BN - Brunei Darussalam 2
DO - Repubblica Dominicana 2
GR - Grecia 2
KR - Corea 2
KW - Kuwait 2
NI - Nicaragua 2
SK - Slovacchia (Repubblica Slovacca) 2
SV - El Salvador 2
UY - Uruguay 2
BA - Bosnia-Erzegovina 1
BG - Bulgaria 1
BH - Bahrain 1
CI - Costa d'Avorio 1
CR - Costa Rica 1
DK - Danimarca 1
GE - Georgia 1
GN - Guinea 1
HN - Honduras 1
HT - Haiti 1
HU - Ungheria 1
IS - Islanda 1
JM - Giamaica 1
LA - Repubblica Popolare Democratica del Laos 1
LU - Lussemburgo 1
MK - Macedonia 1
NP - Nepal 1
OM - Oman 1
PA - Panama 1
RO - Romania 1
SI - Slovenia 1
TT - Trinidad e Tobago 1
XK - ???statistics.table.value.countryCode.XK??? 1
Totale 5.979
Città #
Moscow 500
Dublin 496
Singapore 395
Ashburn 288
Hong Kong 286
Nyköping 277
Dallas 253
Chandler 86
Princeton 86
Medford 85
Los Angeles 84
Des Moines 64
Messina 54
Pune 46
The Dalles 42
Council Bluffs 39
Redondo Beach 39
Beijing 37
Buffalo 37
São Paulo 34
Munich 29
Brooklyn 28
Tianjin 25
Rio de Janeiro 22
Boardman 20
Ho Chi Minh City 20
New York 19
Nuremberg 18
Tokyo 14
Wilmington 14
Montreal 13
Warsaw 13
Johannesburg 12
Orem 12
Turku 12
Vienna 12
San Francisco 11
Atlanta 10
Hanoi 10
Phoenix 10
Amsterdam 9
Frankfurt am Main 9
Porto Alegre 9
Stockholm 9
Belo Horizonte 8
Catania 8
Düsseldorf 8
Jiaxing 8
Rome 8
San Jose 8
Santa Clara 8
Brno 7
Campinas 7
Chennai 7
Denver 7
Guarulhos 7
Jinan 7
Palermo 7
Boston 6
Charlotte 6
Chicago 6
London 6
Ningbo 6
Toronto 6
Goiânia 5
Helsinki 5
Lappeenranta 5
Manchester 5
Norwalk 5
Poplar 5
Recife 5
São Bernardo do Campo 5
Amman 4
Araras 4
Augusta 4
Baghdad 4
Bexley 4
Curitiba 4
Dhaka 4
Hyderabad 4
Joinville 4
Lauterbourg 4
Manaus 4
Mexico City 4
Nova Iguaçu 4
Salvador 4
Taizhou 4
Tashkent 4
Wroclaw 4
Ankara 3
Belford Roxo 3
Bismarck 3
Bogotá 3
Brasília 3
Cairo 3
Campina Grande 3
Cape Town 3
Carapicuíba 3
Catanduva 3
Caxias do Sul 3
Totale 3.870
Nome #
Guidelines for the use and interpretation of assays for monitoring autophagy (4th edition) 291
A Novel Serum-Based Diagnosis of Alzheimer's Disease Using an Advanced Phage-Based Biochip 142
Applications of CRISPR-Cas9 in Alzheimer's Disease and Related Disorders 119
ACAT1 gene ablation increases 24(S)-hydroxycholesterol content in the brain and ameliorates amyloid pathology in mice with AD 102
BACE1 Elevation is Involved in Amyloid Plaque Development in the Triple Transgenic Model of Alzheimer‘s Disease: Differential Aβ Antibody Labeling of Early-Onset Axon Terminal Pathology 100
Age-dependent changes in TDP-43 levels in a mouse model of Alzheimer disease are linked to Aß oligomers accumulation 93
Age- and region-dependent alterations in Abeta-degrading enzymes: implications for Abeta-induced disorders 92
Age-dependent sexual dimorphism in cognition and stress response in the 3xTg-AD mice 92
Accumulation of C-terminal fragments of transactive response DNA-binding protein 43 leads to synaptic loss and cognitive deficits in human TDP-43 transgenic mice 89
Multipotential Role of Growth Factor Mimetic Peptides for Osteochondral Tissue Engineering 87
Amyloid deposition precedes tangle formation in a triple transgenic model of Alzheimer‘s disease 87
Aberrant intracellular localization of H3k4me3 demonstrates an early epigenetic phenomenon in Alzheimer's disease 84
Amyloid beta and the longest-lived rodent: the naked mole-rat as a model for natural protection from Alzheimer's disease 82
Alzheimer's disease: Abeta, tau and synaptic dysfunction 81
Abeta immunotherapy leads to clearance of early, but not late, hyperphosphorylated tau aggregates via the proteasome 81
Physiologic Response Evaluation of Human Foetal Osteoblast Cells within Engineered 3D-Printed Polylactic Acid Scaffolds 80
Administration of a selective beta 2 adrenergic receptor antagonist exacerbates neuropathology and cognitive deficits in a mouse model of Alzheimer's disease 78
An RNAi-Mediated Reduction in Transcription Factor Nrf-2 Blocks the Positive Effects of Dimethyl Fumarate on Metabolic Stress in Alzheimer's Disease 77
Autophagic/lysosomal dysfunction in Alzheimer's disease 75
Acute tau knockdown in the hippocampus of adult mice causes learning and memory deficits 75
Blocking Abeta42 accumulation delays the onset and progression of tau pathology via the C terminus of heat shock protein70-interacting protein: a mechanistic link between Abeta and tau pathology 73
Amyloid deposits show complexity and intimate spatial relationship with dendrosomatic plasma membranes: an electron microscopic 3D reconstruction analysis in 3xTg-AD mice and aged canine 72
Generation of a Biotin-Tagged Dual-Display Phage 70
The ubiquitin-proteasome system in Alzheimer‘s disease 69
A dynamic relationship between intracellular and extracellular pools of Abeta 69
Androgens regulate the development of neuropathology in a triple transgenic mouse model of Alzheimer‘s disease 69
Maternal choline supplementation ameliorates Alzheimer's disease pathology by reducing brain homocysteine levels across multiple generations 69
Epigenetic Changes in Alzheimer's Disease: DNA Methylation and Histone Modification 67
The Role of the Transcription Factor Nrf2 in Alzheimer's Disease: Therapeutic Opportunities 66
Necroptosis activation in Alzheimer's disease 61
Temporal profile of amyloid-beta (Abeta) oligomerization in an in vivo model of Alzheimer disease. A link between Abeta and tau pathology 61
Can We Treat Neurodegenerative Proteinopathies by Enhancing Protein Degradation? 60
Enhanced caffeine-induced Ca2+ release in the 3xTg-AD mouse model of Alzheimer‘s disease 60
Experience-dependent regulation of vesicular zinc in male and female 3xTg-AD mice 58
Inducing autophagy by rapamycin before, but not after, the formation of plaques and tangles ameliorates cognitive deficits 58
Intracellular amyloid-beta in Alzheimer‘s disease 57
Increased intraneuronal resting [Ca2+] in adult Alzheimer‘s disease mice 57
Lithium reduces tau phosphorylation but not A beta or working memory deficits in a transgenic model with both plaques and tangles 57
Inclusion body myositis-like phenotype induced by transgenic overexpression of beta APP in skeletal muscle 55
beta(2) Adrenergic Receptor, Protein Kinase A (PKA) and c-Jun N-terminal Kinase (JNK) Signaling Pathways Mediate Tau Pathology in Alzheimer Disease Models 55
Triple-transgenic model of Alzheimer‘s disease with plaques and tangles: intracellular Abeta and synaptic dysfunction 54
Ibuprofen reduces Abeta, hyperphosphorylated tau and memory deficits in Alzheimer mice 53
Lipopolysaccharide-induced inflammation exacerbates tau pathology by a cyclin-dependent kinase 5-mediated pathway in a transgenic model of Alzheimer‘s disease 53
Genetic suppression of beta 2-adrenergic receptors ameliorates tau pathology in a mouse model of tauopathies 53
The mammalian target of rapamycin at the crossroad between cognitive aging and Alzheimer's disease 52
Progesterone and estrogen regulate Alzheimer-like neuropathology in female 3xTg-AD mice 52
Reduction of soluble Abeta and tau, but not soluble Abeta alone, ameliorates cognitive decline in transgenic mice with plaques and tangles 52
M1 receptors play a central role in modulating AD-like pathology in transgenic mice 52
Caspase-cleavage of tau is an early event in Alzheimer disease tangle pathology 52
Central insulin dysregulation and energy dyshomeostasis in two mouse models of Alzheimer's disease 51
Diffusion of docosahexaenoic and eicosapentaenoic acids through the blood-brain barrier: An in situ cerebral perfusion study 51
mTOR and neuronal cell cycle reentry: How impaired brain insulin signaling promotes Alzheimer's disease 51
Enhanced ryanodine receptor recruitment contributes to Ca2+ disruptions in young, adult, and aged Alzheimer's disease mice 51
Silicon‐Based Sensing Surface for Alzheimer's Disease Diagnosis by Phages Probes 51
Congo red and thioflavin-T analogs detect Abeta oligomers 50
Chronic nicotine administration exacerbates tau pathology in a transgenic model of Alzheimer's disease 50
Genetic Reduction of Mammalian Target of Rapamycin Ameliorates Alzheimer's Disease-Like Cognitive and Pathological Deficits by Restoring Hippocampal Gene Expression Signature 50
Generation of a helper phage for the fluorescent detection of peptide-target interactions by dual-display phages 49
Chronic neuron-specific tumor necrosis factor-alpha expression enhances the local inflammatory environment ultimately leading to neuronal death in 3xTg-AD mice 49
Early correlation of microglial activation with enhanced tumor necrosis factor-alpha and monocyte chemoattractant protein-1 expression specifically within the entorhinal cortex of triple transgenic Alzheimer‘s disease mice 49
Enhanced neuronal excitability in the absence of neurodegeneration induces cerebellar ataxia 49
Impaired adult neurogenesis in the dentate gyrus of a triple transgenic mouse model of Alzheimer‘s disease 49
Inhibition of soluble TNF signaling in a mouse model of Alzheimer‘s disease prevents pre-plaque amyloid-associated neuropathology 47
Validation of a 2-day water maze protocol in mice 47
Modeling behavioral and neuronal symptoms of Alzheimer‘s disease in mice: a role for intraneuronal amyloid 47
Dyrk1 inhibition improves Alzheimer's disease-like pathology 47
Collapsin response mediator protein-2 hyperphosphorylation is an early event in Alzheimer‘s disease progression 46
Genetically augmenting tau levels does not modulate the onset or progression of Abeta pathology in transgenic mice 46
Glucocorticoids Exacerbate Cognitive Deficits in TDP-25 Transgenic Mice via a Glutathione-Mediated Mechanism: Implications for Aging, Stress and TDP-43 Proteinopathies 46
Neural stem cells improve memory in an inducible mouse model of neuronal loss 46
Mammalian target of rapamycin hyperactivity mediates the detrimental effects of a high sucrose diet on Alzheimer's disease pathology 45
Oxidative Damage and Amyloid-beta Metabolism in Brain Regions of the Longest-Lived Rodents 45
Reduced protein turnover mediates functional deficits in transgenic mice expressing the 25 kDa C-terminal fragment of TDP-43 45
Naturally secreted amyloid-beta increases mammalian target of rapamycin (mTOR) activity via a PRAS40-mediated mechanism 45
Identification of learning-induced changes in protein networks in the hippocampi of a mouse model of Alzheimer's disease 45
Peripherally expressed neprilysin reduces brain amyloid burden: A novel approach for treating Alzheimer‘s disease 45
Innovative Silicon-Based Sensing Strategy for the Alzheimer’s Disease Detection by Phage Display 44
The role of nicotinic acetylcholine receptors in Alzheimer‘s disease 44
Reversible epigenetic histone modifications and Bdnf expression in neurons with aging and from a mouse model of Alzheimer's disease 44
How longevity research can lead to therapies for Alzheimer's disease: The rapamycin story 44
Intraneuronal Abeta causes the onset of early Alzheimer‘s disease-related cognitive deficits in transgenic mice 44
Toxic role of K+ channel oxidation in mammalian brain 44
Reducing Ribosomal Protein S6 Kinase 1 Expression Improves Spatial Memory and Synaptic Plasticity in a Mouse Model of Alzheimer's Disease 44
Reduction of the cerebrovascular volume in a transgenic mouse model of Alzheimer‘s disease 43
Enhanced ryanodine-mediated calcium release in mutant PS1-expressing Alzheimer‘s mouse models 43
Molecular interplay between mammalian target of rapamycin (mTOR), amyloid-beta, and Tau: effects on cognitive impairments 42
Rapamycin rescues TDP-43 mislocalization and the associated low molecular mass neurofilament instability 42
Life-long rapamycin administration ameliorates age-dependent cognitive deficits by reducing IL-1β and NMDA signaling 42
Genetically altering Abeta distribution from the brain to the vasculature ameliorates tau pathology 41
Methylene blue reduces Aβ levels and rescues early cognitive deficit by increasing proteasome activity 41
Temporal and regional progression of Alzheimer's disease-like pathology in 3xTg-AD mice 41
The Collagen Chaperone HSP47 Is a New Interactor of APP that Affects the Levels of Extracellular Beta-Amyloid Peptides 40
Genetic reduction of Nrf2 exacerbates cognitive deficits in a mouse model of Alzheimer's disease 40
CBP gene transfer increases BDNF levels and ameliorates learning and memory deficits in a mouse model of Alzheimer‘s disease 40
Pim1 inhibition as a novel therapeutic strategy for Alzheimer's disease 39
The role of mTOR signaling in Alzheimer disease 39
Sortilin is required for toxic action of Aβ oligomers (AβOs): Extracellular AβOs trigger apoptosis, and intraneuronal AβOs impair degradation pathways 39
mTOR regulates tau phosphorylation and degradation: implications for Alzheimer's disease and other tauopathies 37
Paving the Way for New Clinical Trials for Alzheimer's Disease 37
Cognitive decline typical of FTLD in transgenic mice expressing the 25-kDa C-terminal fragment of TDP-43 37
Totale 6.026
Categoria #
all - tutte 30.350
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 30.350


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202192 0 0 0 0 0 0 0 0 0 0 92 0
2021/2022326 9 0 0 1 5 4 41 22 5 0 3 236
2022/20231.021 107 67 48 22 36 100 21 47 544 4 20 5
2023/2024388 5 26 13 103 9 57 0 10 22 22 27 94
2024/20251.695 12 26 29 40 188 32 68 155 537 107 192 309
2025/20262.590 251 271 287 291 385 1.105 0 0 0 0 0 0
Totale 6.112